Important Notice: This site is no longer being maintained.
Please visit the new Municode site for the latest information.

9.49 – Synthetic Alternative Drugs

9.49.010 – Definitions

For purposes of this Chapter, the following definitions shall apply unless the context clearly indicates or requires different meaning:

  1. “Product containing a synthetic alternative drug” means any product containing a synthetic cannabinoid, stimulant or psychedelic/hallucinogen, as those terms are defined herein such as, but not limited to, the examples of brand names or identifiers listed on Exhibit “A” attached hereto and incorporated herein.
  2. “Synthetic cannabinoid” means any laboratory-created compound that functions similar to the active ingredient in marijuana, tetrahydrocannabinol (THC), including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog (including isomers, esters, ethers, salts, and salts of isomers) containing a cannabinoid receptor agonist, including but not limited to:
    • JWH-007 (1-pentyl-2-methyl-3-(1-naphthoyl)indole)
    • JWH-015 ((2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone)
    • JWH-018 (1-pentyl-3-(1-naphthoyl)indole)
    • JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole)
    • JWH-073 (naphthalene-1-yl-(1-butylindol-3-yl)methanone)
    • JWH-081 (4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone)
    • JWH-098 (4-methoxynaphthalen-1-yl-(1-pentyl-2-methylindol-3-yl)methanone)
    • JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole)
    • JWH-164 (7-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone)
    • JWH-200 (1-(2-morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone)
    • JWH-203 (2-(2-chlorophenyl)-1-(1-pentylindol-3-yl)ethanone)
    • JWH-210 (4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone)
    • JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole)
    • JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole)
    • JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole)
    • HU-210 ((6aR,1OaR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,1Oa-tetrahydrobenzo [c]chromen-1-ol)
    • HU-211 ((6aS,1OaS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,1Oa-tetrahydrobenzo [c]chromen-1-ol)
    • HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol)
    • HU-331 ((3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione)
    • CP 55,940 (2-[(1R, 2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]- 5-(2-methyloctan-2-yl)phenol)
    • CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5- (2-methyloctan-2-yl)phenol) and its homologues
    • WIN 55,212-2((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de)-1,4-benzoxazin-6-yl]-1-nepthalenylmethanone)
    • RCS-4 ((4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)menthanone)
    • RCS-8(1-(2-cyclohexylethyl)-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone)
  3. “Synthetic stimulant” means any compound that mimics the effects of any federally controlled Schedule I substance such as cathinone, methcathinone, MDMA and M D E A, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog (including salts, isomers, and salts of isomers) containing substances which have a stimulant effect on the central nervous system, including, but not limited to:
    • 3-Fluoromethcathinone
    • 4-Fluoromethcathinone (other name:  flephedrone)
    • 3,4-Methylenedioxymethcathinone (other name:  methylone, MDMC)
    • 3,4-Methylenedioxypyrovalerone (other name:  MDPV)
    • 4-Methylmethcathinone (other names:  mephedrone, 4-MMC)
    • 4-Methoxymethcathinone (other names:  methedrone, bk-PMMA, PMMC)
    • 4-Ethylmethcathinone (other name: 4-EMC)
    • Ethcathinone
    • Beta-keto-N-methylbenzodioxyolylpropylamine (other names:  butylone, bk-MBDB)
    • Napthylpyrovalerone (other names:  naphyrone, NRG-1)
    • N,N-dimethylcathinone (other name:  metamfepramone)
    • Alpha-pyrrolidinopropiophenone (other name:  alpha-PPP)
    • 4-methoxy-alpha-pyrrolidinopropiophenone (other name:  MOPPP)
    • 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (other name:  MDPPP)
    • Alpha-pyrrolidinovalerophenone (other name:  alpha-PVP)
    • 6,7-kihydro-5H-indeno(5,6-d)-1,3-dioxal-6-amine) (other name MDAI)
    • Any compound that is structurally derived from 2-amino-1-phenyl-1 propanone by modification or substitution in any of the following ways:
      -in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
      -at the 3-position with an alkyl substituent;
      -at the nitrogen atom with alkyl, dialkybenzyl, or methoxybenzyl groups;
      -or by inclusion of the nitrogen atom in a cyclic structure.
  4. “Synthetic psychedelic/hallucinogen” means any compound that mimics the effects of any federally controlled Schedule I substance, including but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog (including salts, isomers, esters, ethers and salts of isomers) containing substances which have a psychedelic/hallucinogenic effect on the central nervous system and/or brain including, but not limited to:
    • 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);
    • 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);
    • 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);
    • 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);
    • 2-(4-(Ethylithio)-2,5-dimethoxyphenyl)ethanamine (2C-T-2);
    • 2-(4-(Isopropylthio)-2,5-dimethoxyphenyl)ethanamine (2C-T-4);
    • 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);
    • 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);
    • 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

9.49.020 – Sale or Delivery

It shall be unlawful for any person to sell, offer for sale or deliver any product containing a synthetic cannabinoid, stimulant or psychedelic/hallucinogen.

9.49.030 – Possession

It shall be unlawful for any person to knowingly possess a product containing a synthetic cannabinoid, stimulant or psychedelic/hallucinogen.

9.49.040 – Use

It shall be unlawful for any person to be under the influence of a synthetic cannabinoid, stimulant or psychedelic/hallucinogen.

9.49.045 – Use, Sale or Delivery of Intoxicating Compounds

A. Use prohibited. No person shall ingest, breathe, inhale or drink any compound, liquid, or chemical containing toluol, hexane, trichloroethylene, acetone, toluene, ethyl acetate, methyl ethyl ketone, trichloroethane, isopropanol, methyl isobutyl ketone, methyl cellosolve acetate, cyclohexanone, the alkaloids atropine, hyoscyamine, or scopolamine, or any other substance for the purpose of inducing a condition of intoxication, stupefaction, depression, giddiness, paralysis or irrational behavior, or in any manner changing, distorting or disturbing the auditory, visual or mental processes. Such condition, so induced shall be deemed to be an intoxicated    condition.

B. Sale or delivery prohibited. No person shall knowingly sell or offer for sale, deliver or give to   any person under 17 years of age, unless upon written order of such person's parent or guardian, any compound, liquid, or chemical containing toluol, hexane, trichloroethylene, acetone, toluene, ethyl acetate, methyl ethyl ketone, trichloroethane, isopropanol, methyl isobutyl ketone, methyl cellosolve acetate, cyclohexanone, or any other substance which will induce an intoxicated condition, as defined herein, when the seller, offeror, or deliverer knows or has reason to know that the compound is intended for use to induce such condition.

C. No person shall knowingly sell or offer for sale, deliver, or give to any person any compound, liquid, or chemical containing alkaloids atropine, hyoscyamine, or scopolamine when the seller, offeror, or deliverer knows or has reason to know that the compound, liquid, or chemical is intended for use to induce an intoxicated condition.

(2018-M-23: § 9)

9.49.050 – Violation – Penalty

Any person, firm or corporation violating any provision of this chapter shall be fined not less than two hundred and fifty ($250) dollars nor more than seven hundred and fifty ($750) dollars for each offense, and a separate offense shall be deemed committed on each day on which a violation occurs or continues.

(2018-M-23: § 10; 2011-M-52: § 1)